Results of endoscopic transsphenoidal pituitary surgery in 40 patients with a growth hormone-secreting macroadenoma

Acta Neurochirurgica

Volumn 153, Issue 7, 2011, Pages 1391-1399

  Wagenmakers, Margreet Albertina E M ^a   Netea Maier, Romana T ^a   Van Lindert, Erik J ^a   Pieters, Gerlach F F M ^a   Grotenhuis, André J A ^a   Hermus, Ad R M M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acromegaly; Endoscopy; Macroadenoma; Pituitary; Transsphenoidal surger

Indexed keywords

ANDROGEN; CABERGOLINE; CORTICOTROPIN; DESMOPRESSIN; ESTRADIOL; FOLLITROPIN; GROWTH HORMONE; HYDROCORTISONE; LEVOTHYROXINE; LUTEINIZING HORMONE; OCTREOTIDE; PEGVISOMANT; PREDNISOLONE; PROLACTIN; SOMATOMEDIN; SOMATOSTATIN DERIVATIVE; TESTOSTERONE; THYROTROPIN; THYROXINE;

ACROMEGALY; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CEREBROSPINAL FLUID DRAINAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIABETES INSIPIDUS; DRUG DOSE REDUCTION; ENDOSCOPIC SURGERY; EPISTAXIS; FEMALE; GAMMA KNIFE RADIOSURGERY; GROWTH HORMONE SECRETING ADENOMA; GROWTH HORMONE SECRETING MACROADENOMA; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; LIQUORRHEA; MALE; MEDICAL RECORD REVIEW; ORAL GLUCOSE TOLERANCE TEST; PERIOPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RELAPSE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR REGRESSION;

ACROMEGALY; ADENOMA; ADULT; AGED; COHORT STUDIES; ENDOSCOPY; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; HYPOPHYSECTOMY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SPHENOID BONE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959540636     PISSN: 00016268     EISSN: 09420940     Source Type: Journal    
DOI: 10.1007/s00701-011-0959-8     Document Type: Article

References (45)

1. Abe T, Ludecke DK (2001) Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145:137-145 (Pubitemid 32707599)
2. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and longterm results. J Clin Endocrinol Metab 83:3411-3418 (Pubitemid 28500865)
3. Bates PR, Carson MN, Trainer PJ, Wass JA (2008) Wide variation in surgical outcomes for acromegaly in the UK. Clin Endocrinol (Oxf) 68:136-142 (Pubitemid 350243493)
4. Beauregard C, Truong U, Hardy J, Serri O (2003) Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58:86-91 (Pubitemid 36098853)
5. Beckers A (2008) Does preoperative somatostatin analog treatment improve surgical cure rates in acromegaly? A new look at an old question. J Clin Endocrinol Metab 93:2975-2977
6. Cappabianca P, Alfieri A, Colao A, Ferone D, Lombardi G, de Divitiis E (1999) Endoscopic endonasal transsphenoidal approach: an additional reason in support of surgery in the management of pituitary lesions. Skull Base Surg 9:109-117 (Pubitemid 29281515)
7. Cappabianca P, Alfieri A, de Divitiis E (1998) Endoscopic endonasal transsphenoidal approach to the sella: towards functional endoscopic pituitary surgery (FEPS). Minim Invasive Neurosurg 41:66-73 (Pubitemid 28293445)
8. Cappabianca P, Alfieri A, Thermes S, Buonamassa S, de Divitiis E (1999) Instruments for endoscopic endonasal transsphenoidal surgery. Neurosurgery 45:392-395
9. Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Cooper SJ, JG HJK, Fougner SL, Bollerslev J (2008) Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure shortterm postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab 93:2984-2990
10. Ceylan S, Koc K, Anik I (2010) Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 112:99-107
11. Charalampaki P, Reisch R, Ayad A, Conrad J, Welschehold S, Perneczky WC (2007) Endoscopic endonasal pituitary surgery: surgical and outcome analysis of 50 cases. J Clin Neurosci 14:410-415 (Pubitemid 46453186)
12. Colao A, Attanasio R, Pivonello R, Cappabianca P, Cavallo LM, Lasio Lodrini A, Lombardi G, Cozzi R (2006) Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91:85-92 (Pubitemid 43069122)
13. Danoff A, Kleinberg D (2003) Somatostatin analogs as primary medical therapy for acromegaly. Endocr 20:291-297 (Pubitemid 36571032)
14. de Divitiis E, Cappabianca P, Cavallo LM (2002) Endoscopic transsphenoidal approach: adaptability of the procedure to different sellar lesions. Neurosurgery 51:699-705
15. Erturk E, Tuncel E, Kiyici S, Ersoy C, Duran C, Imamoglu S (2005) Outcome of surgery for acromegaly performed by different surgeons: importance of surgical experience. Pituitary 8:93-97
16. Feenstra J, de Herder WW, ten Have SM, van den Beld AW, Feelders RA, Janssen JA, van der Lely AJ (2005) Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly. Lancet 365:1644-1646 (Pubitemid 40693415)
17. Freda PU, Katznelson L, van der Lely AJ, Reyes CM, Zhao S, Rabinowitz D (2005) Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. J Clin Endocrinol Metab 90:4465-4473 (Pubitemid 41159328)
18. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM (1999) Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon. QJM 92:741-745
19. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526-529
20. Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141-148
21. Jho HD, Alfieri A (2000) Endoscopic transsphenoidal pituitary surgery: various surgical techniques and recommended steps for procedural transition. Br J Neurosurg 14:432-440
22. Jho HD, Carrau RL (1997) Endoscopic endonasal transsphenoidal surgery: experience with 50 patients. J Neurosurg 87:44-51
23. Kaltsas GA, Isidori AM, Florakis D, Trainer PJ, Camacho-Hubner C, Afshar F, Sabin I, Jenkins JP, Chew SL, Monson JP, Besser GM, Grossman AB (2001) Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86:1645-1652 (Pubitemid 32374917)
24. Karavitaki N, Turner HE, Adams CB, Cudlip S, Byrne JV, Fazal-Sanderson V, Rowlers S, Trainer PJ, Wass JA (2008) Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide. Clin Endocrinol (Oxf) 68:970-975 (Pubitemid 351703951)
25. Katznelson L (2006) Drug insight: primary medical therapy of acromegaly. Nat Clin Pract Endocrinol Metab 2:109-117
26. Koc K, Anik I, Ozdamar D, Cabuk B, Keskin G, Ceylan S (2006) The learning curve in endoscopic pituitary surgery and our experience. Neurosurg Rev 29:298-305
27. Kristof RA, Stoffel-Wagner B, Klingmüller D, Schramm J (1999) Does octreotide treatment improve the surgical results of macroadenomas in acromegaly? A randomized study. Acta Neurochir (Wien) 141:399-405
28. Laws ER (2008) Surgery for acromegaly: evolution of the techniques and outcomes. Rev Endocr Metab Disord 9:67-70
29. Laws ER, Vance ML, Thapar K (2000) Pituitary surgery for the management of acromegaly. Horm Res 53(Suppl 3):71-75
30. Mao Z, Zhu Y, Tang H, Wang D, Zhou J, He D, Lan H, Luo B, Wang H (2010) Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial. Eur J Endocrinol 162:661-666
31. Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(2558-2573):14-12
32. Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202
33. Neggers SJ, van Aken MO, Janssen JA, Feelders RA, de Herder WW, van der Lely AJ (2007) Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegaly. J Clin Endocrinol Metab 92:4598-4601 (Pubitemid 350223432)
34. Nomikos P, Buchfelder M, Fahlbusch R (2005) The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical "cure". Eur J Endocrinol 152:379-387
35. Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A (2005) Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 152:61-66
36. Pieters GF, Smals AG, Kloppenborg PW (1980) Defective suppression of growth hormone after oral glucose loading in adolescence. J Clin Endocrinol Metab 51:265-270 (Pubitemid 10007631)
37. Plöckinger U, Quabbe HJ (2005) Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function
38. Selvarajah D, Webster J, Ross R, Newell-Price J (2005) Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly. Eur J Endocrinol 152:569-574
39. Sheppard MC (2003) Primary medical therapy for acromegaly. Clin Endocrinol (Oxf) 58:387-399
40. Shimon I, Cohen ZR, Ram Z, Hadani M (2001) Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48:1239-1243
41. Swearingen B, Barker FG, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 83:3419-3426 (Pubitemid 28500866)
42. Tabaee A, Anand VK, Barron Y, Hiltzik DH, Brown SM, Kacker A, Mazumdar M, Schwartz TH (2009) Endoscopic pituitary surgery: a systematic review and meta-analysis. J Neurosurg 111:545-554
43. Trepp R, Stettler C, Zwahlen M, Seiler R, Diem P, Christ ER (2005) Treatment outcomes and mortality of 94 patients with acromegaly. Acta Neurochir (Wien) 147:243-251
44. Van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358:1754-1759
45. Van Lindert EJ, Hey O, Boecher-Schwarz H, Perneczky A (1997) Treatment results of acromegaly as analyzed by different criteria. Acta Neurochir (Wien) 139:905-912